Prostate cancer  is the most common form of cancer in men. According to the  American Cancer Society, one in nine  men will be diagnosed with prostate  cancer during his lifetime. It is a statistic that Craig Siegel never expected he'd be among.

Living with Prostate Cancer

Prostate cancer is the most common form of cancer in men. According to the American Cancer Society, one in nine men will be diagnosed with prostate cancer during his lifetime. It is a statistic that Craig Siegel never expected he’d be among.

In October 2015, while visiting his daughter, Craig experienced the urge to urinate with unusual frequency. To make sure that everything was okay, he made an appointment with Dr. Christopher Vulin,  a urologist at Missouri Baptist Medical Center.

“During my exam, Dr. Vulin checked my prostate and told me that it was very large and abnormal,” Craig recalled.

Craig was scheduled for an immediate prostate biopsy. “Because of its size, Dr. Vulin suspected cancer,” Craig explained. “I expected I might have an enlarged prostate, but was surprised that he was worried about cancer because I hadn’t experienced any prolonged warning signs and felt fine.” After he received the biopsy results, Dr. Vulin’s suspicions were confirmed, and Craig was told that he had prostate cancer.


Craig met with Dr. Paul Mehan, Missouri Baptist Medical Center oncologist and medical director of the Cancer Center. “Dr. Mehan explained that my cancer was in advanced stages with Gleason scores in the 9s and 10s,” Craig said.

As defined by the Prostate Conditions Education  Council,  the  Gleason  Score  is a grading system used by doctors to determine the aggressiveness of prostate cancer and helps them choose the best treatment for patients. Higher scores mean that the cancer is more likely to grow and spread quickly.

“After I heard my score, I felt like I was doomed,” Craig recalled.

Dr. Mehan told Craig about new clinical trial results involving chemotherapy combined with standard androgen deprivation therapy (ADT), which lowers testosterone levels that stimulate the growth of prostate cancer cells.

“The treatment goal was to prolong my life, and the life expectancy of participants with similarly advanced cancer who received chemotherapy was 17 months longer than those who received standard therapy,” Craig said.

After three months of treatment, Craig’s prostate-specific antigen (PSA) had lowered dramatically, and his urinary symptoms resolved.


In January 2017, Craig’s PSA started to rise again. “A CT scan showed that the cancer was spreading,” Craig said. “This time, I underwent oral chemotherapy and palliative radiation to shrink the tumor and to slow the cancer’s progression.

Craig continued radiation for six weeks and oral chemotherapy until early summer when his doctors discovered new metastases in his lungs and adrenal gland.


Craig met with Dr. Mehan again to discuss treatment options. “Dr. Mehan told me that genetic testing could identify gene mutations that might respond to targeted therapy,” said Craig.

“Genetic counseling is very important,” explained MoBap’s Genetic Counselor Heidi Beaver. “For patients like Craig  who are struggling with cancer, we explain the genetic basis of all cancer and what a hereditary cancer gene variant may mean to them. This allows them to make an informed decision about potential treatments, as well as options to address risk for other cancers in the future.”

Genetic testing on Craig’s cancer revealed that he was a candidate for a targeted immunotherapy that had just received FDA approval.

“We hoped the treatment would boost the ability of his body’s immune system to fight the cancer,” Dr. Mehan said.





≤ 6





The Prostate Cancer Foundation states that, usually, prostate cancer with a low Gleason score, is less aggressive. On the other hand, prostate cancer with a high Gleason score is typically more aggressive and places the patient at a higher risk for recurrence.


During September 2017, Craig started immunotherapy through intravenous infusion. Over the following months, Craig saw his elevated PSA levels drop from 14.95 to an undetectable level of less than 0.014.

Furthermore, the sites in Craig’s body where cancer had spread have normalized, and the disease is no longer evident. “He experienced a complete response in a very short time,” Dr. Mehan said.

“I feel incredibly lucky,” Craig said, as he looks forward to continuing his two-year immunotherapy treatment regimen until October 2019.


Looking back on his experience, Craig offers advice to men who might  be overdue for prostate exams and seeing their physicians. “Get regular checkups and don’t forego health and cancer screenings,” he recommended. “If you are diagnosed with cancer, consider genetic testing.

Now, Craig is looking forward to the future and having the opportunity to  spend  time with his family and pursuing his photography hobby.

“Because of all the ups and downs I was undergoing, I wasn’t sure if I would be alive to see the total eclipse in 2017,” Craig added. “Now, thanks to the care of Dr. Vulin, Dr. Mehan and the entire MoBap team, I’m looking forward to photographing the next one in 2024.”


The American Cancer Society reports that early prostate cancer is usually silent with no symptoms. Signs and symptoms of more advanced prostate cancer may appear as:

  • Problems urinating, including a slow or weak urinary stream
  • The need to urinate more frequently, especially at night
  • Blood in the urine or semen
  • Trouble getting an erection (erectile dysfunction or ED)
  • Pain in the hips, back, or chest
  • Weakness or numbness in the legs or feet
  • Loss of bladder or bowel control

While these problems may be caused by something other than prostate cancer, talk to your health care provider if you have any of these symptoms.

Related Content

Find a Doctor or Make an Appointment

Our new search tool will help you choose a doctor or health care provider that is best for you or your family.

Search Now

Palliative Care: Helping Patients Live Their Best Lives

Lynn’s husband Steve was diabetic and diagnosed with end stage renal disease 11 years ago. Without warning, Steve’s condition turned critical three years ago. Desperate for guidance and strength, Lynn was connected to April and the Palliative Care team at Missouri Baptist Medical Center.

Learn More keyboard_arrow_right
Thumbnail of landing page of the MoBap Cancer Research website

Cancer Research - the leading edge of finding a cure.

Missouri Baptist is part of Heartland Cancer Research, one of 34 community networks that comprise the National Cancer Institute Community Oncology Research Program (NCORP).

Learn More keyboard_arrow_right

Advanced Treatment When You Need It Most

Missouri Baptist Cancer Center is committed to offering patients the most advanced treatment and surgical options available. As early adopters of new technology, Missouri Baptist Cancer Center offers both  RapidArc™ Therapy and the da Vinci® Surgical System.

Learn More keyboard_arrow_right
Prostate cancer  is the most common form of cancer in men. According to the  American Cancer Society, one in nine  men will be diagnosed with prostate  cancer during his lifetime. It is a statistic that Craig Siegel never expected he'd be among.

Living with Prostate Cancer

Prostate cancer is the most common form of cancer in men. According to the American Cancer Society, one in nine men will be diagnosed with prostate cancer during his lifetime.

Learn More keyboard_arrow_right

Cancer Registry Report

The Cancer Registry is known for its substantial supportive role in the Missouri Baptist Medical Center’s Cancer Program. The Registry works with physicians, administrators, healthcare providers and planners to provide support for cancer program development, to ensure compliance to regulatory reporting requirements and standards, and to serve as a primary resource for cancer information and statistical information.

Learn More keyboard_arrow_right

Meet the MoBap Cancer Care Team

You’ll be glad to know that the physicians at Missouri Baptist Cancer Center are all leading cancer specialists. Our physician team includes board-certified specialists that are involved in investigational research and use the latest diagnostic and treatment options for our cancer patients.

Learn More keyboard_arrow_right

Rapid Referral

We understand that every second counts in the fight against cancer. With every cancer diagnosis comes a host of possible emotional responses:  uncertainty, anger, and most of all – fear.  That is why we see patients within 48 hours after referral to our Cancer Center.

Learn More keyboard_arrow_right

Bring down the swelling (and your stress).

Lymphedema is a type of chronic swelling that can occur if there is damage to the lymphatic system or if the lymphatic system becomes overloaded by excess fluid due to infection or other medical issues, such as surgery, radiation or trauma to the lymph vessels. 

As the first and only National Lymphedema Network  Affiliate Treatment Center in the St. Louis area, find out how the Center for Outpatient Therapy and Wellness can help.

Learn More keyboard_arrow_right

Racing the Clock: Treating Pancreatic Cancer

Pancreatic cancer affects an estimated 38,000 people each year in the United States. The best results with treatment are achieved when surgery is used for removal of the tumor.

Learn More keyboard_arrow_right
Alissa Nicks, founder of Alissa’s Hope, presents her fourth annual gift of $5,000 to MoBap’s Breast HealthCare Center (BHCC).

Donations from Alissa’s Hope Provide Financial Help for Patients

Alissa Nicks, founder of Alissa’s Hope, and Dan Schultz, a volunteer with Alissa’s Hope, continued the charity's tradition of providing funds for screenings that can save lives, awarding grants to two MoBap cancer screening programs.

Learn More keyboard_arrow_right

An Inside Look

Since launching in November 2014, the Missouri Baptist Medical Center Computed Tomography (CT) Lung Cancer Screening has screened 2,594 people for early-stage lung cancer. Forty-six of them had cancer. 

David Patton is one of those. Read how the nurse navigator assisted him through the program.

Learn More keyboard_arrow_right

Rural Outreach Brings Clinical Trials to Patients

Patients like Mary Elise, a retired teacher in Ste. Genevieve, can take part in advanced clinical research thanks to the Missouri Baptist Cancer Center involvement with the Heartland Cancer Research NCORP. As part of the TAILORx trial, Mary Elise help researchers studying the effects of chemotherapy on early-state cancer.

Learn More keyboard_arrow_right

Giving Back - Theresa's Story

Read how Theresa gives back to others.
Thousands of cancer survivors are living proof that cancer can be treated successfully and people can go on to live fulfilling, happy and healthy lives. 

Learn More keyboard_arrow_right

Should You be Screened for Lung Cancer?

Lung cancer is one of the most common cancers in the world. Often the disease does not show symptoms until it has progressed to advanced stages, when it is difficult to treat and chances of survival decrease. A low-radiation-dose CT scan can detect lung cancer at its earliest stages, making treatment both easier and more effective.

Learn More keyboard_arrow_right

New Patients and Family Information

Learn More keyboard_arrow_right

Cancer Support Center

Our Cancer Support Center at the Cancer Center at Missouri Baptist focuses on cancer diagnosis, treatment, emotional support and community resources.

Learn More keyboard_arrow_right

Take 5 for Lung Cancer

Lung cancer is one of the most common cancers in the world; yet recent research shows most people know very little about the disease. Did you know that more people in the United States die from lung cancer than any other type of cancer?

Learn More keyboard_arrow_right

Breast Cancer Risk Assessment & Genetic Counseling

The Breast Cancer Risk Assessment & Genetic Counseling Program at Missouri Baptist Medical Center provides comprehensive breast cancer screenings and customized surveillance plan for patients with an increased risk of breast cancer.

Learn More keyboard_arrow_right